You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,415,311


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,415,311 protect, and when does it expire?

Patent 8,415,311 protects SOOLANTRA and is included in one NDA.

This patent has thirty-two patent family members in twenty-three countries.

Summary for Patent: 8,415,311
Title:Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Abstract: Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
Inventor(s): Manetta; Vincent (Bordentown, NJ), Watkins; Gary R. (Piscataway, NJ)
Assignee: Galderma S.A. (Cham, CH)
Application Number:13/310,633
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,415,311
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,415,311

Introduction

United States Patent 8,415,311, hereafter referred to as the '311 Patent, is a significant intellectual property asset that protects a specific invention. To fully comprehend the implications and boundaries of this patent, it is crucial to delve into its scope, claims, and the broader patent landscape.

Patent Overview

The '311 Patent is listed in the FDA Orange Book, which indicates its relevance to pharmaceutical products. This patent is associated with a drug or medical treatment, and understanding its details can provide insights into its legal and market implications.

Scope of the Patent

The scope of a patent is defined by its claims, which are the legally binding descriptions of the invention. The '311 Patent likely covers a specific method, composition, or use related to pharmaceuticals, given its inclusion in the FDA Orange Book.

Claims Analysis

  • Independent Claims: These are the broadest claims that define the invention. They set the outer limits of what is protected under the patent.
  • Dependent Claims: These claims are narrower and build upon the independent claims, often adding specific details or limitations.
  • Claim Construction: The interpretation of claims is critical in determining the scope of the patent. This involves analyzing the language used in the claims, the specification, and any relevant prosecution history[4].

Patent Claims Research Dataset

For a deeper analysis, the USPTO's Patent Claims Research Dataset can be a valuable resource. This dataset provides detailed information on claims from U.S. patents, including those granted between 1976 and 2014. It includes claim-level statistics and document-level statistics, which can help in understanding the scope and breadth of the '311 Patent's claims[3].

Expiration and Exclusivity

Patents have a limited lifespan, typically 20 years from the earliest filing date. The '311 Patent's expiration date is crucial for understanding when the protected invention will enter the public domain. Additionally, any patent extensions or additional periods of exclusivity can extend this period[2].

Patent Landscape

The patent landscape surrounding the '311 Patent includes other related patents and applications. Here are some key aspects to consider:

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including all related applications filed at participating IP Offices. This can help in identifying similar or overlapping patents[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This tool is useful for visualizing the search results for the same invention produced by several offices on a single page[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can reveal whether similar inventions have been patented abroad. This is essential for understanding the global patent landscape[1].

Litigation and Enforcement

Patents like the '311 Patent can be involved in litigation, particularly if there are allegations of infringement. Understanding the legal framework and any past or ongoing litigation related to the patent can provide insights into its enforceability and the potential risks or opportunities associated with it[4].

Practical Applications

The '311 Patent, being related to pharmaceuticals, has practical applications in the treatment of specific medical conditions. For instance, if the patent covers a new formulation or method of treatment, it could have significant implications for healthcare providers, patients, and competitors in the market.

Economic Impact

The economic impact of the '311 Patent can be substantial. Patents in the pharmaceutical sector often provide exclusive rights that can influence market dynamics, pricing, and access to treatments. The expiration of such a patent can lead to the entry of generic competitors, which can significantly alter the market landscape.

Key Takeaways

  • Scope and Claims: The '311 Patent's scope is defined by its claims, which are critical for understanding what is protected.
  • Expiration and Exclusivity: Knowing the expiration date and any extensions is vital for planning and strategy.
  • Patent Landscape: Understanding related patents and global filings helps in navigating the intellectual property environment.
  • Litigation and Enforcement: Past or ongoing litigation can impact the patent's enforceability and market implications.
  • Practical Applications: The patent's practical applications in healthcare are crucial for stakeholders.
  • Economic Impact: The patent's economic impact on the market and competitors is significant.

FAQs

Q: What is the primary purpose of the '311 Patent? A: The primary purpose of the '311 Patent is to protect a specific invention related to pharmaceuticals, as indicated by its inclusion in the FDA Orange Book.

Q: How do I determine the scope of the '311 Patent? A: The scope is determined by analyzing the claims of the patent, which are the legally binding descriptions of the invention.

Q: Where can I find information on the expiration date of the '311 Patent? A: The expiration date can be found through resources like the FDA Orange Book or by searching the USPTO database.

Q: What is the significance of the Global Dossier in relation to the '311 Patent? A: The Global Dossier helps in viewing the patent family and related applications filed at participating IP Offices, providing a comprehensive view of the patent landscape.

Q: How does litigation affect the enforceability of the '311 Patent? A: Litigation can impact the enforceability by challenging the validity of the patent or alleging infringement, which can lead to legal battles and potential changes in the patent's status.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,415,311

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp SOOLANTRA ivermectin CREAM;TOPICAL 206255-001 Dec 19, 2014 AB RX Yes Yes 8,415,311 ⤷  Subscribe Y TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA. ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,415,311

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France03 05048Apr 24, 2003

International Family Members for US Patent 8,415,311

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1620113 ⤷  Subscribe C300756 Netherlands ⤷  Subscribe
European Patent Office 1620113 ⤷  Subscribe CA 2015 00045 Denmark ⤷  Subscribe
European Patent Office 1620113 ⤷  Subscribe PA2015033 Lithuania ⤷  Subscribe
European Patent Office 1620113 ⤷  Subscribe 122015000079 Germany ⤷  Subscribe
European Patent Office 1620113 ⤷  Subscribe 92915 Luxembourg ⤷  Subscribe
European Patent Office 1620113 ⤷  Subscribe 56/2015 Austria ⤷  Subscribe
European Patent Office 1620113 ⤷  Subscribe 15C0069 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.